14:30

ASPIRIN AND RIVAROXABAN IN VASCULAR DOSE ARE THE NEW GOLD STANDARD REGIMEN FOR PATIENTS WITH LEAD

Bauersachs R. *

14:43

CLOPIDOGREL IS STILL THE TREATMENT OF CHOICE FOR PATIENTS WITH LEAD

Twine C. *

14:56

CAROTID ARTERY STENTING IS EQUIVALENT TO CAROTID ENDARTERECTOMY FOR ASYMPTOMATIC PATIENTS

Halliday A. *

15:09

CAROTID ENDARTERECTOMY REMAINS THE REVASCULARIZATION METHOD OF CHOICE FOR MOST ASYMPTOMATIC PATIENTS

De Borst G.J. *

15:22

US VIEW ON THE TREATMENT OF ASYMPTOMATIC PATIENTS

Aburahma A. *

15:35

DO WE NEED PACLITAXEL IN TREATMENT OF PAD PATIENTS? NO

Saucy F. *

15:48

DO WE NEED PACLITAXEL IN TREATMENT OF PAD PATIENTS? YES

Behrendt C.A. *